Alpha-interferon therapy for chronic hepatitis C may induce acute allograft rejection in kidney transplant patients with failed allografts.
暂无分享,去创建一个
L. Rostaing | J. Izopet | N. Kamar | C. Guilbeau-Frugier | D. Ribes | M. Mehrenberger | F. Sallusto | A. Modesto | Hugo Wéclawiack
[1] J. Dumortier,et al. Rejection Under Alpha Interferon Therapy in Liver Transplant Recipients , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] L. Rostaing,et al. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant. , 2006, Transplantation.
[3] J. Lake,et al. Emerging Issues in Hepatitis C Virus‐Positive Liver and Kidney Transplant Recipients , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] K. Abbott,et al. Acute Renal Allograft Rejection Following Pegylated IFN‐α Treatment for Chronic HCV in a Repeat Allograft Recipient on Hemodialysis: A Case Report , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] J. Pestana,et al. Efficacy and tolerance of interferon‐α in the treatment of chronic Hepatitis C in end‐stage renal disease patients on hemodialysis , 2006, Liver international : official journal of the International Association for the Study of the Liver.
[6] S. Hoşoğlu,et al. Efficacy and tolerability of pegylated‐interferon alpha‐2a in hemodialysis patients with chronic hepatitis C , 2006, Journal of gastroenterology and hepatology.
[7] A. Bruchfeld,et al. Hepatitis C Infection, Time in Renal-Replacement Therapy, and Outcome after Kidney Transplantation , 2004, Transplantation.
[8] L. Rostaing,et al. Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation. , 2003, Journal of the American Society of Nephrology : JASN.
[9] R. Colvin,et al. Acute Humoral Rejection in Hepatitis C‐Infected Renal Transplant Recipients Receiving Antiviral Therapy , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] A. Kirk,et al. Hepatitis C Virus Seropositivity at the Time of Renal Transplantation in the United States: Associated Factors and Patient Survival , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[11] J. Torras,et al. Hepatitis C Virus Infection and de Novo Glomerular Lesions in Renal Allografts , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[12] G. Danovitch,et al. Histopathological features of hepatitis C in renal transplant candidates [see comment]. , 2000, Transplantation.
[13] A. Sanyal,et al. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation , 1999, American Journal of Gastroenterology.
[14] T. Wada,et al. Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] P Coriat,et al. Impact of hepatitis B and C virus on kidney transplantation outcome , 1999, Hepatology.
[16] S. Thung,et al. Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients , 1999, American Journal of Gastroenterology.
[17] R. Chung,et al. Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy. , 1998, Transplantation.
[18] C. Schmid,et al. Effect of hepatitis C infection and renal transplantation on survival in end-stage renal disease1 , 1998 .
[19] C. Schmid,et al. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. , 1998, Kidney international.
[20] R. Finch,et al. Acute exacerbation of vasculitis during interferon-alpha therapy for hepatitis C-associated cryoglobulinaemia. , 1998, The Journal of infection.
[21] L. Rostaing,et al. High Rate of Hepatitis C Virus Clearance in Hemodialysis Patients after Interferon-α Therapy , 1997 .
[22] B. Julian,et al. The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[23] C. Schmid,et al. Long-term follow-up of hepatitis C virus infection among organ transplant recipients: implications for policies on organ procurement. , 1997, Transplantation.
[24] L. Rostaing,et al. High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapy. , 1997, The Journal of infectious diseases.
[25] L. Rostaing,et al. Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C. , 1996, Nephron.
[26] John P. Johnson,et al. INTERFERON-α-INDUCED ACUTE RENAL ALLOGRAFT REJECTION , 1995 .
[27] S. Wadler,et al. Interferon-induced acute renal failure: a case report and literature review , 1995, Medical oncology.
[28] T. Starzl,et al. Interferon-alpha-induced acute renal allograft rejection. , 1995, Transplantation.